Clinical Trial Update: Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ruxolitinib phosphate in previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Ruxolitinib phosphate (ruxolitinib phosphate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Untreated Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-04-21